This page is part of the PACIO Transitions of Care Implementation Guide (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: AllergyIntolerance BSJ-AllergyACE
clinicalStatus: Active
verificationStatus: Confirmed
category: Medication
criticality: High Risk
code: Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)
lastOccurrence: 2011-10
Substance | Manifestation |
captopril 12.5 MG Oral Tablet | Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder) |